https://lsiusasummit.com
LSI USA '25: Partner with the Leaders Building Medtech
Bringing together industry visionaries, thought leaders, and professionals from around the
world.
LSI USA '25: Partner with the Leaders Building Medtech Read the First Edition of The Lens, a new magazine by LSI Back to Main Website Attendees Startups Agenda Resources Sponsors Hotel News Register Now LSI USA '25 LSI Asia '25 LSI Europe '25 Register before next rate increase Partner with the Leaders Building Medtech March 17th - 21st | Waldorf Astoria, Monarch Beach | Dana Point, CA Secure Your Spot Hotel Almost Full Apply to Present On-stage presentation to a full house of investors Apply to Exhibit Private demo and partnering space in our Innovator Pavilion Sponsorship Opportunities Elevate your brand at the epicenter of the industry Trusted By The Companies Pioneering What’s Next the Ethos of our events World-class executives, convening in world-class venues to do real business In 2024, LSI USA convened 1,500 executives from emerging companies, venture capital and private equity firms, family offices, global strategics, professional service providers, and more. LSI USA will never be held in a chaotic convention center. It is a curated forum where real business gets done, hosted in world-class venues where senior executives want to do business. Speakers and Attendees Industry-leading executives from emerging companies, venture capital and private equity firms, family offices, investment banks, global strategics, and more. View all Attendees Celine Martin Company Group Chairman, Cardiovascular & Specialty Solutions Group Johnson & Johnson Jay Watkins Co-Chair and Partner Sonder Capital Lisa Earnhardt Executive Vice President and Group President Abbott Paul LaViolette Managing Partner & Chief Operating Officer SV Health Investors John Ryan Managing Director Wells Fargo Strategic Capital Greg Madden Managing Partner SV Health Investors Nick Pachuda Innovation & New Ventures Precision Life Science Partners Michael Braun Senior Venture Partner 415 Capital View all Attendees Present at LSI USA ‘25 LSI USA ‘25 Presenting Companies Present to a full house of investors and strategics alongside the CEOs and Founders building technology that is shaping the future of healthcare. Apply to Present View All Presenters Portal Instruments Presenter Portal Instruments Patrick Anquetil CEO Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration. Visit website. Portal Instruments Presenter Portal Instruments Patrick Anquetil CEO Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration. Visit website. Navigation Sciences Presenter Navigation Sciences Alan Lucas CEO Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. Visit website. Navigation Sciences Presenter Navigation Sciences Alan Lucas CEO Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. Visit website. Bionic Vision Technologies Presenter Bionic Vision Technologies Ash Attia CEO BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit. Visit website. Bionic Vision Technologies Presenter Bionic Vision Technologies Ash Attia CEO BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit. Visit website. SentiAR Presenter SentiAR Berk Tas CEO Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website. SentiAR Presenter SentiAR Berk Tas CEO Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website. LEM Surgical Presenter LEM Surgical Yossi Bar CEO LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website. LEM Surgical Presenter LEM Surgical Yossi Bar CEO LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website. Field Orthopaedics Presenter Field Orthopaedics Patryk Kania CEO and President Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website. Field Orthopaedics Presenter Field Orthopaedics Patryk Kania CEO and President Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website. Juniper Biomedical Presenter Juniper Biomedical David Constantine CEO Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website. Juniper Biomedical Presenter Juniper Biomedical David Constantine CEO Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website. Ossiform Presenter Ossiform Thea Wulff Olesen CEO Ossiform is the developer of fully resorbable patient-matched implants, tailored to improve bone healing outcomes in orthopedics and spine. According to Ossiform: We Print Bone™. Visit website. Ossiform Presenter Ossiform Thea Wulff Olesen CEO Ossiform is the developer of fully resorbable patient-matched implants, tailored to improve bone healing outcomes in orthopedics and spine. According to Ossiform: We Print Bone™. Visit website. CDX Medical Technologies Presenter CDX Medical Technologies Gopal K. Chopra Co-CEO CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website CDX Medical Technologies Presenter CDX Medical Technologies Gopal K. Chopra Co-CEO CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website Novian Health Presenter Novian Health Henry (Chip) Appelbaum President & CEO Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation. Visit website. Novian Health Presenter Novian Health Henry (Chip) Appelbaum President & CEO Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation. Visit website. SamanTree Medical Presenter SamanTree Medical Olivier Delporte CEO SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory. Visit website. SamanTree Medical Presenter SamanTree Medical Olivier Delporte CEO SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory. Visit website. Agada Medical Presenter Agada Medical Scott Gunnigle CEO Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options. Visit website. Agada Medical Presenter Agada Medical Scott Gunnigle CEO Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options. Visit website. Brain4Care Presenter Brain4Care Carlos Bremer President North American Division Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website. Brain4Care Presenter Brain4Care Carlos Bremer President North American Division Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website. Spiro Roboitcs Presenter Spiro Roboitcs Dimitri Sokolov CEO Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation. Visit website. Spiro Roboitcs Presenter Spiro Roboitcs Dimitri Sokolov CEO Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation. Visit website. Adaptyx Biosceinces Presenter Adaptyx Biosceinces Vijit Sabnis Co-Founder Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology. Adaptyx Biosceinces Presenter Adaptyx Biosceinces Vijit Sabnis Co-Founder Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology. Aulisa Medical Presenter Aulisa Medical Augustine Lien CEO Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults. Visit website. Aulisa Medical Presenter Aulisa Medical Augustine Lien CEO Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults. Visit website. Axena Health Presenter Axena Health Eileen Maus CEO Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence. Visit website. Axena Health Presenter Axena Health Eileen Maus CEO Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence. Visit website. Azra Care Presenter Azra Care Christian Pean CEO Azra Care is a healthcare technology company specializing in integrating SaaS AI solutions into orthopedic care to enhance patient outcomes and operational efficiency. The company’s platform leverages advanced analytics and machine learning to support evidence-based, equity-focused clinical decision-making and population health management. Azra Care is committed to transforming orthopedic surgery and care delivery through innovative, value-based approaches that address racial disparities and improve healthcare access for all. Visit website. Azra Care Presenter Azra Care Christian Pean CEO Azra Care is a healthcare technology company specializing in integrating SaaS AI solutions into orthopedic care to enhance patient outcomes and operational efficiency. The company’s platform leverages advanced analytics and machine learning to support evidence-based, equity-focused clinical decision-making and population health management. Azra Care is committed to transforming orthopedic surgery and care delivery through innovative, value-based approaches that address racial disparities and improve healthcare access for all. Visit website. Bimini Health Tech Presenter Bimini Health Tech Bradford Conlan CEO Bimini Healthtech is developing a diverse portfolio of regenerative technologies and therapeutics that enable people to live better lives. The company is commercializing and investigating autologous and allogenic products and therapies intended for use at the point-of-care to eliminate the need for matching patients with donors. Visit website. Bimini Health Tech Presenter Bimini Health Tech Bradford Conlan CEO Bimini Healthtech is developing a diverse portfolio of regenerative technologies and therapeutics that enable people to live better lives. The company is commercializing and investigating autologous and allogenic products and therapies intended for use at the point-of-care to eliminate the need for matching patients with donors. Visit website. CairnSurgical Presenter CairnSurgical David Danielsen CEO CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website. CairnSurgical Presenter CairnSurgical David Danielsen CEO CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website. Neuronoff Presenter Neuronoff Manfred Franke CEO Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration. Visit website. Neuronoff Presenter Neuronoff Manfred Franke CEO Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration. Visit website. ConnCons Presenter ConnCons Jochen Hampe CEO ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website. ConnCons Presenter ConnCons Jochen Hampe CEO ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website. KelaHealth Presenter KelaHealth Bora Chang Founder & CEO The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website. KelaHealth Presenter KelaHealth Bora Chang Founder & CEO The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website. LifeSignals Presenter LifeSignals Surendar Magar CEO Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software. Visit website. LifeSignals Presenter LifeSignals Surendar Magar CEO Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software. Visit website. Linshom Medical Presenter Linshom Medical Richard Hughen CEO Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops. Visit website. Linshom Medical Presenter Linshom Medical Richard Hughen CEO Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops. Visit website. Neuroelectrics Presenter Neuroelectrics Ana Maiques CEO Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. Visit website. Neuroelectrics Presenter Neuroelectrics Ana Maiques CEO Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. Visit website. Osteal Therapeutics Presenter Osteal Therapeutics David Thompson CEO Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients. Visit website. Osteal Therapeutics Presenter Osteal Therapeutics David Thompson CEO Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients. Visit website. PercuSense Presenter PercuSense Brian Kannard Founder PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment. Visit website. PercuSense Presenter PercuSense Brian Kannard Founder PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment. Visit website. Sana Health Presenter Sana Health Richard Hanbury CEO Non-invasive bio-therapeutic device for pain management. Visit website. Sana Health Presenter Sana Health Richard Hanbury CEO Non-invasive bio-therapeutic device for pain management. Visit website. Sonofii Presenter Sonofii Roberta Lee CEO Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system. Visit website. Sonofii Presenter Sonofii Roberta Lee CEO Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system. Visit website. Arsenal Medical Presenter Arsenal Medical Upma Sharma President & CEO Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage. Visit website. Arsenal Medical Presenter Arsenal Medical Upma Sharma President & CEO Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage. Visit website. Vektor Medical Presenter Vektor Medical Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visite website. Vektor Medical Presenter Vektor Medical Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visite website. THINK Surgical Presenter THINK Surgical Stuart Simpson CEO THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website. THINK Surgical Presenter THINK Surgical Stuart Simpson CEO THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website. Nutromics Presenter Nutromics Peter Vranes CEO Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software. Visit website. Nutromics Presenter Nutromics Peter Vranes CEO Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software. Visit website. Sparta Biomedical Presenter Sparta Biomedical Dimitrios Angelis Co-Founder The first osseointegrative biomimetic knee cartilage implant. Visit website. Sparta Biomedical Presenter Sparta Biomedical Dimitrios Angelis Co-Founder The first osseointegrative biomimetic knee cartilage implant. Visit website. Flow Medical Presenter Flow Medical Jennifer Fried CEO Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website. Flow Medical Presenter Flow Medical Jennifer Fried CEO Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website. PhotoniCare Presenter PhotoniCare Cary Vance CEO The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates. Visit website. PhotoniCare Presenter PhotoniCare Cary Vance CEO The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates. Visit website. Pulnovo Medical Presenter Pulnovo Medical Erika Chen Business Development Lead Pulnovo Medical is developing radiofrequency (RF) solutions for the treatment of pulmonary hypertension. PADN is a multipolar synchronous pulmonary artery RF ablation catheter that is intended to treat pulmonary hypertension by ablating the sympathetic nerve at the target site. The device is capable of point-to-point ablation of pulmonary sympathetic nerves. Visit website. Pulnovo Medical Presenter Pulnovo Medical Erika Chen Business Development Lead Pulnovo Medical is developing radiofrequency (RF) solutions for the treatment of pulmonary hypertension. PADN is a multipolar synchronous pulmonary artery RF ablation catheter that is intended to treat pulmonary hypertension by ablating the sympathetic nerve at the target site. The device is capable of point-to-point ablation of pulmonary sympathetic nerves. Visit website. EP Solutions Presenter EP Solutions Marcin Golebicki CEO EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website. EP Solutions Presenter EP Solutions Marcin Golebicki CEO EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website. Joint Preservation Innovations Presenter Joint Preservation Innovations Sanjeev Bhatia CEO Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery. Visit website. Joint Preservation Innovations Presenter Joint Preservation Innovations Sanjeev Bhatia CEO Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery. Visit website. Satisfai Health Presenter Satisfai Health Solveig Johannessen CEO Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website. Satisfai Health Presenter Satisfai Health Solveig Johannessen CEO Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website. CAPS Medical Presenter CAPS Medical Ilan Uchitel CEO & Co-Founder CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. Clinically tested ,working towards commercialization. Visit website. CAPS Medical Presenter CAPS Medical Ilan Uchitel CEO & Co-Founder CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. Clinically tested ,working towards commercialization. Visit website. GT Medical Technologies Presenter GT Medical Technologies Per Langoe CEO GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complication while optimizes therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTile's provide uniform radiation-source spacing to ensure even dose distribution. Visit website. GT Medical Technologies Presenter GT Medical Technologies Per Langoe CEO GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complication while optimizes therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTile's provide uniform radiation-source spacing to ensure even dose distribution. Visit website. Centerline Biomedical Presenter Centerline Biomedical Gulam Khan CEO Centerline is a Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS®) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure. Centerline Biomedical Presenter Centerline Biomedical Gulam Khan CEO Centerline is a Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS®) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure. Altra Presenter Altra Matthew Morris CEO & Founder Altra has engineered a novel infusion pump, inspired by the human heart, to address adverse events and challenges associated with drug delivery. The company's infusion pump utilizes dual chamber pumping technology to enable safe and effective infusion therapy. Visit website. Altra Presenter Altra Matthew Morris CEO & Founder Altra has engineered a novel infusion pump, inspired by the human heart, to address adverse events and challenges associated with drug delivery. The company's infusion pump utilizes dual chamber pumping technology to enable safe and effective infusion therapy. Visit website. Hy2Care Presenter Hy2Care Leo Smit CEO Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage. Visit website. Hy2Care Presenter Hy2Care Leo Smit CEO Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage. Visit website. EMBioSys Presenter EMBioSys Chris Barron CEO EMBioSys develops non-invasive, electrode-free, home-use wearable garments that utilize low level induced electric fields (iEFs) for the treatment of solid metastatic cancers. iEF Therapy hinders metastasis while potentiating new opportunities to improve the standard of care and patient outcomes. Visit website. EMBioSys Presenter EMBioSys Chris Barron CEO EMBioSys develops non-invasive, electrode-free, home-use wearable garments that utilize low level induced electric fields (iEFs) for the treatment of solid metastatic cancers. iEF Therapy hinders metastasis while potentiating new opportunities to improve the standard of care and patient outcomes. Visit website. Tensor Surgical Presenter Tensor Surgical Justin Anderson CEO Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures. Visit website. Tensor Surgical Presenter Tensor Surgical Justin Anderson CEO Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures. Visit website. Portal Instruments Presenter Portal Instruments Patrick Anquetil CEO Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration. Visit website. Portal Instruments Presenter Portal Instruments Patrick Anquetil CEO Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration. Visit website. Navigation Sciences Presenter Navigation Sciences Alan Lucas CEO Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. Visit website. Navigation Sciences Presenter Navigation Sciences Alan Lucas CEO Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. Visit website. Bionic Vision Technologies Presenter Bionic Vision Technologies Ash Attia CEO BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit. Visit website. Bionic Vision Technologies Presenter Bionic Vision Technologies Ash Attia CEO BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit. Visit website. SentiAR Presenter SentiAR Berk Tas CEO Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website. SentiAR Presenter SentiAR Berk Tas CEO Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website. LEM Surgical Presenter LEM Surgical Yossi Bar CEO LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website. LEM Surgical Presenter LEM Surgical Yossi Bar CEO LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website. Field Orthopaedics Presenter Field Orthopaedics Patryk Kania CEO and President Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website. Field Orthopaedics Presenter Field Orthopaedics Patryk Kania CEO and President Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website. Juniper Biomedical Presenter Juniper Biomedical David Constantine CEO Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website. Juniper Biomedical Presenter Juniper Biomedical David Constantine CEO Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website. Ossiform Presenter Ossiform Thea Wulff Olesen CEO Ossiform is the developer of fully resorbable patient-matched implants, tailored to improve bone healing outcomes in orthopedics and spine. According to Ossiform: We Print Bone™. Visit website. Ossiform Presenter Ossiform Thea Wulff Olesen CEO Ossiform is the developer of fully resorbable patient-matched implants, tailored to improve bone healing outcomes in orthopedics and spine. According to Ossiform: We Print Bone™. Visit website. CDX Medical Technologies Presenter CDX Medical Technologies Gopal K. Chopra Co-CEO CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website CDX Medical Technologies Presenter CDX Medical Technologies Gopal K. Chopra Co-CEO CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website Novian Health Presenter Novian Health Henry (Chip) Appelbaum President & CEO Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation. Visit website. Novian Health Presenter Novian Health Henry (Chip) Appelbaum President & CEO Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation. Visit website. SamanTree Medical Presenter SamanTree Medical Olivier Delporte CEO SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory. Visit website. SamanTree Medical Presenter SamanTree Medical Olivier Delporte CEO SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory. Visit website. Agada Medical Presenter Agada Medical Scott Gunnigle CEO Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options. Visit website. Agada Medical Presenter Agada Medical Scott Gunnigle CEO Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options. Visit website. Brain4Care Presenter Brain4Care Carlos Bremer President North American Division Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website. Brain4Care Presenter Brain4Care Carlos Bremer President North American Division Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website. Spiro Roboitcs Presenter Spiro Roboitcs Dimitri Sokolov CEO Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation. Visit website. Spiro Roboitcs Presenter Spiro Roboitcs Dimitri Sokolov CEO Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation. Visit website. Adaptyx Biosceinces Presenter Adaptyx Biosceinces Vijit Sabnis Co-Founder Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology. Adaptyx Biosceinces Presenter Adaptyx Biosceinces Vijit Sabnis Co-Founder Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology. Aulisa Medical Presenter Aulisa Medical Augustine Lien CEO Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults. Visit website. Aulisa Medical Presenter Aulisa Medical Augustine Lien CEO Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults. Visit website. Axena Health Presenter Axena Health Eileen Maus CEO Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence. Visit website. Axena Health Presenter Axena Health Eileen Maus CEO Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence. Visit website. Azra Care Presenter Azra Care Christian Pean CEO Azra Care is a healthcare technology company specializing in integrating SaaS AI solutions into orthopedic care to enhance patient outcomes and operational efficiency. The company’s platform leverages advanced analytics and machine learning to support evidence-based, equity-focused clinical decision-making and population health management. Azra Care is committed to transforming orthopedic surgery and care delivery through innovative, value-based approaches that address racial disparities and improve healthcare access for all. Visit website. Azra Care Presenter Azra Care Christian Pean CEO Azra Care is a healthcare technology company specializing in integrating SaaS AI solutions into orthopedic care to enhance patient outcomes and operational efficiency. The company’s platform leverages advanced analytics and machine learning to support evidence-based, equity-focused clinical decision-making and population health management. Azra Care is committed to transforming orthopedic surgery and care delivery through innovative, value-based approaches that address racial disparities and improve healthcare access for all. Visit website. Bimini Health Tech Presenter Bimini Health Tech Bradford Conlan CEO Bimini Healthtech is developing a diverse portfolio of regenerative technologies and therapeutics that enable people to live better lives. The company is commercializing and investigating autologous and allogenic products and therapies intended for use at the point-of-care to eliminate the need for matching patients with donors. Visit website. Bimini Health Tech Presenter Bimini Health Tech Bradford Conlan CEO Bimini Healthtech is developing a diverse portfolio of regenerative technologies and therapeutics that enable people to live better lives. The company is commercializing and investigating autologous and allogenic products and therapies intended for use at the point-of-care to eliminate the need for matching patients with donors. Visit website. CairnSurgical Presenter CairnSurgical David Danielsen CEO CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website. CairnSurgical Presenter CairnSurgical David Danielsen CEO CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website. Neuronoff Presenter Neuronoff Manfred Franke CEO Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration. Visit website. Neuronoff Presenter Neuronoff Manfred Franke CEO Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration. Visit website. ConnCons Presenter ConnCons Jochen Hampe CEO ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website. ConnCons Presenter ConnCons Jochen Hampe CEO ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website. KelaHealth Presenter KelaHealth Bora Chang Founder & CEO The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website. KelaHealth Presenter KelaHealth Bora Chang Founder & CEO The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website. LifeSignals Presenter LifeSignals Surendar Magar CEO Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software. Visit website. LifeSignals Presenter LifeSignals Surendar Magar CEO Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software. Visit website. Linshom Medical Presenter Linshom Medical Richard Hughen CEO Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops. Visit website. Linshom Medical Presenter Linshom Medical Richard Hughen CEO Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops. Visit website. Neuroelectrics Presenter Neuroelectrics Ana Maiques CEO Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. Visit website. Neuroelectrics Presenter Neuroelectrics Ana Maiques CEO Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. Visit website. Osteal Therapeutics Presenter Osteal Therapeutics David Thompson CEO Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients. Visit website. Osteal Therapeutics Presenter Osteal Therapeutics David Thompson CEO Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients. Visit website. PercuSense Presenter PercuSense Brian Kannard Founder PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment. Visit website. PercuSense Presenter PercuSense Brian Kannard Founder PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment. Visit website. Sana Health Presenter Sana Health Richard Hanbury CEO Non-invasive bio-therapeutic device for pain management. Visit website. Sana Health Presenter Sana Health Richard Hanbury CEO Non-invasive bio-therapeutic device for pain management. Visit website. Sonofii Presenter Sonofii Roberta Lee CEO Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system. Visit website. Sonofii Presenter Sonofii Roberta Lee CEO Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system. Visit website. Arsenal Medical Presenter Arsenal Medical Upma Sharma President & CEO Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage. Visit website. Arsenal Medical Presenter Arsenal Medical Upma Sharma President & CEO Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage. Visit website. Vektor Medical Presenter Vektor Medical Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visite website. Vektor Medical Presenter Vektor Medical Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visite website. THINK Surgical Presenter THINK Surgical Stuart Simpson CEO THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website. THINK Surgical Presenter THINK Surgical Stuart Simpson CEO THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website. Nutromics Presenter Nutromics Peter Vranes CEO Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software. Visit website. Nutromics Presenter Nutromics Peter Vranes CEO Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software. Visit website. Sparta Biomedical Presenter Sparta Biomedical Dimitrios Angelis Co-Founder The first osseointegrative biomimetic knee cartilage implant. Visit website. Sparta Biomedical Presenter Sparta Biomedical Dimitrios Angelis Co-Founder The first osseointegrative biomimetic knee cartilage implant. Visit website. Flow Medical Presenter Flow Medical Jennifer Fried CEO Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website. Flow Medical Presenter Flow Medical Jennifer Fried CEO Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website. PhotoniCare Presenter PhotoniCare Cary Vance CEO The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates. Visit website. PhotoniCare Presenter PhotoniCare Cary Vance CEO The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates. Visit website. Pulnovo Medical Presenter Pulnovo Medical Erika Chen Business Development Lead Pulnovo Medical is developing radiofrequency (RF) solutions for the treatment of pulmonary hypertension. PADN is a multipolar synchronous pulmonary artery RF ablation catheter that is intended to treat pulmonary hypertension by ablating the sympathetic nerve at the target site. The device is capable of point-to-point ablation of pulmonary sympathetic nerves. Visit website. Pulnovo Medical Presenter Pulnovo Medical Erika Chen Business Development Lead Pulnovo Medical is developing radiofrequency (RF) solutions for the treatment of pulmonary hypertension. PADN is a multipolar synchronous pulmonary artery RF ablation catheter that is intended to treat pulmonary hypertension by ablating the sympathetic nerve at the target site. The device is capable of point-to-point ablation of pulmonary sympathetic nerves. Visit website. EP Solutions Presenter EP Solutions Marcin Golebicki CEO EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website. EP Solutions Presenter EP Solutions Marcin Golebicki CEO EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website. Joint Preservation Innovations Presenter Joint Preservation Innovations Sanjeev Bhatia CEO Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery. Visit website. Joint Preservation Innovations Presenter Joint Preservation Innovations Sanjeev Bhatia CEO Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery. Visit website. Satisfai Health Presenter Satisfai Health Solveig Johannessen CEO Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website. Satisfai Health Presenter Satisfai Health Solveig Johannessen CEO Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website. CAPS Medical Presenter CAPS Medical Ilan Uchitel CEO & Co-Founder CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. Clinically tested ,working towards commercialization. Visit website. CAPS Medical Presenter CAPS Medical Ilan Uchitel CEO & Co-Founder CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. Clinically tested ,working towards commercialization. Visit website. GT Medical Technologies Presenter GT Medical Technologies Per Langoe CEO GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complication while optimizes therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTile's provide uniform radiation-source spacing to ensure even dose distribution. Visit website. GT Medical Technologies Presenter GT Medical Technologies Per Langoe CEO GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complication while optimizes therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTile's provide uniform radiation-source spacing to ensure even dose distribution. Visit website. Centerline Biomedical Presenter Centerline Biomedical Gulam Khan CEO Centerline is a Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS®) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure. Centerline Biomedical Presenter Centerline Biomedical Gulam Khan CEO Centerline is a Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS®) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure. Altra Presenter Altra Matthew Morris CEO & Founder Altra has engineered a novel infusion pump, inspired by the human heart, to address adverse events and challenges associated with drug delivery. The company's infusion pump utilizes dual chamber pumping technology to enable safe and effective infusion therapy. Visit website. Altra Presenter Altra Matthew Morris CEO & Founder Altra has engineered a novel infusion pump, inspired by the human heart, to address adverse events and challenges associated with drug delivery. The company's infusion pump utilizes dual chamber pumping technology to enable safe and effective infusion therapy. Visit website. Hy2Care Presenter Hy2Care Leo Smit CEO Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage. Visit website. Hy2Care Presenter Hy2Care Leo Smit CEO Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage. Visit website. EMBioSys Presenter EMBioSys Chris Barron CEO EMBioSys develops non-invasive, electrode-free, home-use wearable garments that utilize low level induced electric fields (iEFs) for the treatment of solid metastatic cancers. iEF Therapy hinders metastasis while potentiating new opportunities to improve the standard of care and patient outcomes. Visit website. EMBioSys Presenter EMBioSys Chris Barron CEO EMBioSys develops non-invasive, electrode-free, home-use wearable garments that utilize low level induced electric fields (iEFs) for the treatment of solid metastatic cancers. iEF Therapy hinders metastasis while potentiating new opportunities to improve the standard of care and patient outcomes. Visit website. Tensor Surgical Presenter Tensor Surgical Justin Anderson CEO Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures. Visit website. Tensor Surgical Presenter Tensor Surgical Justin Anderson CEO Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures. Visit website. Hear what industry leaders think LSI is my favorite medtech conference of the year. It is the most efficient way to connect with high-quality emerging medtech companies, large strategics, and the investors that fund these businesses. Kyle Dempsey, MD Partner, MVM Partners Hear what industry leaders think LSI events are absolute game-changers and an unparalleled opportunity for us to engage with promising innovators and fellow strategics and investors in an efficient way. Chris Eso VP, Global Head of Corporate & Business Development, M&A & Ventures Medtronic Hear what industry leaders think LSI is the place to be. The caliber of active investors, the track record of the innovators, and the wealth of knowledge you garner are unparalleled in our industry. The future of medtech is bright because of LSI. Rui Jing Jiang CEO, Avisi Technologies Hear what industry leaders think LSI is making a major investment in our innovation ecosystem and has created a must-attend meeting for medtech investors, large and small company leaders, and service providers. Josh Makower Co-Founder & Director, Stanford Byers Center for Biodesign, Stanford University Hear what industry leaders think LSI has emerged as one of the must attend events, bringing the global medtech community together, with an emphasis on fostering meaningful connections, sharing insights, and driving innovation. Antoine Papiernik Managing Partner & Chairman, Sofinnova Partners What is LSI USA ‘25? Authentic panels and keynotes with the leaders in Medtech View Full Agenda Date TBD Keynote with Lisa Earnhardt, Executive Vice President & Group President, Medical Devices at Abbott Date TBD Advancing Neuromodulation Therapy for Mixed Urinary Incontinence and Investing in Amber Therapeutics Date TBD Medtech Market and Venture Investment Outlook:
State of Seed and Growth in 2025 Date TBD What Matters to Corporate VCs in 2025? Date TBD Human and Financial Capital: How Winning Management Teams Hire, Develop, and Retain Talent to Scale Want to Speak on a Panel With Other Leaders? Register March 18th - 22nd, 2025 Waldorf Astoria | Monarch Beach Resort Sponsorship opportunities Elevate your brand and accelerate growth at the epicenter of the industry View All Sponsors Apply to Sponsor Location Information Rooms are available from March 1 7-22 with a three night minimum. Waldorf Astoria Monarch Beach Resort The LSI room block is now open and a limited number of rooms are available at a special rate. The room block sells out early every year. Please do not wait to book your room. Book With Special LSI Rate Need more help? Contact us Special LSI Rates Available Additional hotel options Nearby Lodging Additional hotel options Featured 5min The Ritz-Carlton Niguel 600m from the Venue Website 10min Laguna Cliffs Marriott Resort & Spa 1.2km from the Venue Website 10min Marriott Dana Point San Juan Capistrano 1.2km from the Venue Website 10min Montage 1.2km from the Venue Website 10min Hilton Doheny Doubletree 1.2km from the Venue Website 10min Marriott Dana Point Residence Inn 1.2km from the Venue Website 5min Blue Lantern Inn 1.2km from the Venue Website 10min Casa Laguna 1.2km from the Venue Website 15min Inn at Mission 1.2km from the Venue Website 10min The Ranch 1.2km from the Venue Website 15min Surf & Sand 1.2km from the Venue Website Featured 5min The Ritz-Carlton Niguel 600m from the Venue Website 10min Laguna Cliffs Marriott Resort & Spa 1.2km from the Venue Website 10min Marriott Dana Point San Juan Capistrano 1.2km from the Venue Website 10min Montage 1.2km from the Venue Website 10min Hilton Doheny Doubletree 1.2km from the Venue Website 10min Marriott Dana Point Residence Inn 1.2km from the Venue Website 5min Blue Lantern Inn 1.2km from the Venue Website 10min Casa Laguna 1.2km from the Venue Website 15min Inn at Mission 1.2km from the Venue Website 10min The Ranch 1.2km from the Venue Website 15min Surf & Sand 1.2km from the Venue Website Secure Your Spot Hear what industry leaders think Resources from the LSI Alumni Our resource library contains thousands of insightful executive sessions from previous events, captivating photos, and the latest alumni news. Dive in today to prepare for your next LSI experience. Video Library Photo Gallery Alumni News Partnering will soon open for all registered attendees Register below to start building your profile in the app. Work with us Accelerate your business We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media. Market Intelligence LSI Europe ‘24 LSI Asia ‘25 Contact Customer Login Events LSI USA ‘25 LSI Asia ‘25 LSI Europe ‘25 Market Intelligence Full Platform Custom Services Procedure Volumes
en
en
1729731781
https://lsiusasummit.com
isi arac ceysas?
Macaay abtam?